CSIMarket
 


Moderna Inc   (MRNA)
Other Ticker:  
 

Moderna Inc 's Tangible Leverage Ratio

MRNA's quarterly Tangible Leverage Ratio and Total Liabilities, Tangible Equity growth




MRNA Tangible Leverage Ratio (Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
Y / Y Tangible Equity Change 127.49 % 133.9 % - - -
Y / Y Total Liabilities Change 1632.92 % 1977.12 % 46231.38 % 12910.55 % 10252.46 %
Tangible Leverage Ratio MRQ 1.41 2.31 1.86 0.69 0.19
Overall Ranking # # # # #
Seq. Tangible Equity Change 74.67 % 49.84 % -7.19 % -6.35 % 79.59 %
Seq. Total Liabilities Change 6.62 % 85.59 % 151.69 % 247.97 % 27.8 %



Tangible Leverage Ratio second quarter 2021 Comment
Despite net new borrowings of 6.62% Moderna Inc managed to improve Tangible Leverage Ratio in the second quarter 2021 to 1.41, below company's average Tangible Leverage Ratio.

Within Biotechnology & Pharmaceuticals industry in the second quarter 2021, 69 other companies have achieved lower Tangible Leverage Ratio than Moderna Inc . While total ranking remained unchanged compare to previous quarter at no. .

Explain Tangible Leverage Ratio?
What is MRNA Market Share?
Tangible Leverage Ratio second quarter 2021 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 70
Healthcare Sector # 289
Overall Market # 1152


Tangible Leverage Ratio Statistics
High Average Low
216.5 14.57 0.19
(Dec 31 2011)   (Jun 30 2020)




Financial Statements
Moderna Inc 's Tangible Equity $ 6,704 Millions Visit MRNA's Balance sheet
Moderna Inc 's Total Liabilities $ 9,449 Millions Visit MRNA's Balance sheet
Source of MRNA's Sales Visit MRNA's Sales by Geography




Companies with similar Tangible Leverage Ratio in the quarter endingJun 30 2021, within Biotechnology & Pharmaceuticals Industry Tangible Leverage RatioJun 30 2021 MRQ Total LiabilitiesJun 30 2021 MRQ Tangible Equity
Coherus Biosciences inc   3.77 $ 574.878  Millions$ 152.657  Millions
Sunwin Stevia International Inc   3.37 $ 24.887  Millions$ 7.388  Millions
Novavax inc   3.31 $ 2,004.025  Millions$ 605.987  Millions
Cidara Therapeutics Inc   3.04 $ 47.955  Millions$ 15.789  Millions
Wave Life Sciences Ltd   2.52 $ 54.934  Millions$ 21.842  Millions
Eyenovia inc   2.40 $ 21.592  Millions$ 8.991  Millions
Azurrx Biopharma Inc   2.26 $ 5.490  Millions$ 2.430  Millions
Surgalign Holdings Inc   2.22 $ 116.998  Millions$ 52.812  Millions
Emergent Biosolutions Inc   2.13 $ 1,371.500  Millions$ 644.000  Millions
Cytomx Therapeutics Inc   2.11 $ 271.487  Millions$ 128.910  Millions
Inhibrx Inc   1.96 $ 86.698  Millions$ 44.319  Millions
Urogen Pharma Ltd   1.73 $ 97.497  Millions$ 56.271  Millions
Codiak Biosciences Inc   1.65 $ 85.771  Millions$ 51.864  Millions
Outlook Therapeutics Inc   1.58 $ 20.133  Millions$ 12.749  Millions
Strongbridge Biopharma plc  1.55 $ 30.390  Millions$ 19.558  Millions
Allena Pharmaceuticals Inc   1.42 $ 17.377  Millions$ 12.267  Millions
Moderna Inc   1.41 $ 9,449.000  Millions$ 6,704.000  Millions
Nanostring Technologies Inc   1.33 $ 293.331  Millions$ 219.727  Millions
Armata Pharmaceuticals Inc   1.32 $ 19.662  Millions$ 14.873  Millions
Evelo Biosciences Inc   1.31 $ 81.153  Millions$ 62.093  Millions
Establishment Labs Holdings Inc   1.26 $ 81.250  Millions$ 64.505  Millions
Infinity Pharmaceuticals Inc   1.24 $ 51.458  Millions$ 41.540  Millions
Sangamo Therapeutics Inc   1.12 $ 389.906  Millions$ 347.658  Millions
Adma Biologics Inc   1.07 $ 113.618  Millions$ 105.978  Millions
Unity Biotechnology Inc   1.07 $ 70.346  Millions$ 65.917  Millions
Royalty Pharma Plc  1.04 $ 10,781.234  Millions$ 10,388.103  Millions
Brooklyn Immunotherapeutics Inc   1.03 $ 26.997  Millions$ 26.279  Millions
Gossamer Bio Inc   0.96 $ 211.817  Millions$ 220.693  Millions
Iterum Therapeutics Plc  0.92 $ 43.345  Millions$ 47.195  Millions
Soligenix inc   0.89 $ 13.900  Millions$ 15.596  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

HEI's Profile

Stock Price

HEI's Financials

Business Description

Fundamentals

Charts & Quotes

HEI's News

Suppliers

HEI's Competitors

Customers & Markets

Economic Indicators

HEI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071